Leuprolide Acetate

A synthetic GnRH receptor agonist

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥837.00

670.00

- +
10mg

￥1087.00

870.00

- +
25mg

￥0.00

0.00

- +
50mg

￥1962.00

1570.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci4394
CAS: 74381-53-6
别名: 醋酸亮丙瑞林,Leuprorelin acetate;Lupron
分子式: C61H88N16O14
分子量: 1269.45
纯度: >98%
溶解度: ≥ 126.9 mg/mL in DMSO, ≥ 31.4 mg/mL in EtOH with gentle warming, ≥ 102 mg/mL in Water with gentle warming
储存: Store at -20°C
库存: 现货

Background

Description: IC50 Value: N/A Leuprorelin (INN) or leuprolide acetate (USAN) is a GnRH analog. leuprolide acetate acts as an agonist at pituitary GnRH receptors. By interrupting the normal pulsatile stimulation of, and thus desensitizing, the GnRH receptors, it indirectly downregulates the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to hypogonadism and thus a dramatic reduction in estradiol andtestosterone levels in both sexes. in vitro: The number of DNA 3'-end-labeled cells/cm2 in leiomyomas of control patients and in leiomyomas at the 2nd, 8th, 12th, and 16th weeks of Leuprolide Acetate treatment were at low levels [1]. Testosterone, estradiol and progesterone were also reduced by LA, even though this reduction occurred for progesterone only at the highest LA dosage (10(-6)M; 606.0+/-114.3 ng/ml versus 1524.0+/-246.5 ng/ml; p=0.02) [2]. in vivo: Leuprolide acetate treatment decreases the severity of clinical signs of locomotion, induces a significantly greater body weight gain, increases the MBP and NFs expression, axonal area and cell infiltration in EAE animals [3]. Leuprolide (200 and 300 microg kg(-1) s.c.) per se showed anti-compulsive effect, causing statistically significant inhibition of marble-burying behavior of mice [4]. Clinical trial: Neoadjuvant Abiraterone Acetate Plus Leuprolide Acetate in Men With Localized High Risk Prostate Cancer . Phase 2